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ABSTRACT  Normal and malignant lymphocytes can migrate from the bloodstream  into lymph nodes 
and  Peyer's patches. This process helps distribute  normal  lymphocytes throughout the lymphoid 
system and  may provide a portal  of entry for circulating  malignant  cells. An adhesive  interaction 
between lymphocytes and the endothelium of postcapillary venules is the first step in the migratory 
process. We have recently shown that the simple sugars L-fucose and D-mannose, and an L-fucose- 
rich  polysaccharide  (fucoidin),  can  inhibit this  adhesive  interaction  in  vitro.  We  now  report that 
mannose-6-phosphate,  the structurally  related sugar fructose-l-phosphate,  and a phosphomannan, 
core  polysaccharide  from  the yeast Hansenula  holstii  (PPME) are also potent inhibitors.  Inhibitory 
activity was assessed by incubating  freshly  prepared  suspensions of lymphocytes,  containing the 
various additives, over air-dried,  frozen sections of syngeneic lymph nodes at 7-10°C. Sections were 
then  evaluated  in  the  light  microscope  for the  binding of lymphocytes  to  postcapillary  venules. 
Mannose-6-phosphate  and fructose-l-phosphate were potent inhibitors of lymphocyte attachment 
(one-half maximal inhibition at 2-3 mM). Mannose-l-phosphate and fructose-6-phosphate  had slight 
inhibitory  activity,  while  glucose-l-phosphate,  glucose-6-phosphate,  galactose-l-phosphate,  and 
galactose-6-phosphate  had no significant activity (at 10 mM). In addition, the phosphomannan  core 
polysaccharide  was a potent inhibitor (one-half maximal inhibition at 10-20 ~g/ml); dephosphoryla- 
tion  with  alkaline  phosphatase  resulted  in  loss of  its  inhibitory  activity.  Preincubation  of  the 
lymphocytes, but not the lymph node frozen sections, with PPME resulted in persistent inhibition of 
binding.  Neither  the  monosaccharides  nor  the  polysaccharide  suppressed  protein  synthesis nor 
decreased the viability of the lymphocytes. Furthermore,  inhibitory activity did not correlate with an 
increase in  negative  charge on the  lymphocyte surface (as measured  by cellular  electrophoresis). 
These data suggest that a carbohydrate-binding molecule on the lymphocyte surface, with specificity 
for mannose-phosphates  and  structurally  related  carbohydrates,  may be  involved  in the adhesive 
interaction  mediating lymphocyte recirculation. 
In rodent model systems, normal and malignant lymphocytes 
migrate from the bloodstream into lymph nodes and Peyer's 
patches (1, 2). This process helps distribute normal lympho- 
cytes throughout the body and may provide a mechanism for 
the hematogenous dissemination of lymphoid malignancies. 
Circulating lymphoid cells enter many lymphoid organs by 
migrating across the structurally distinctive postcapillary ven- 
ules known as the high endothelial venules or HEW (3, 4). 
Abbreviations  used in this paper."  HEV,  high endothelial  venule; 
M6P, D-mannose-6-phosphate;  M l P, D-mannose- l-phosphate;  FtP, 
Both in situ and in vitro studies strongly implicate a specific 
adhesive interaction between lymphocytes  and this specialized 
endothelium as  the  initial  step in  migration (5,  6).  In  the 
mouse system, this binding interaction may be responsible 
for the distinctive recirculatory patterns of T-cells and B-cells, 
D-fructose-6-phosphate;  F1P, D-fructose-l-phosphate; PPME,  phos- 
phomannosyl-rich,  core polysaccharide  of mannan derived from the 
yeast  Hansenula holstii; MEM+, minimal essential  medium in Earle's 
salts (without bicarbonate)  supplemented with 1 mg/ml bovine serum 
albumin and buffered  with 40 mM Tricine, pH 7.4; I50, concentration 
for 1/2 maximal inhibition of binding. 
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eral lymph nodes while the latter adhere preferentially to the 
HEV of Peyer's patches (7). Two groups of investigators have 
developed  antibodies  directed  at  the  lymphocyte  surface 
which  selectively block the binding of lymphocytes to HEV 
in frozen sections of lymph nodes (8, 9); in contrast,  binding 
to Peyer's patches is not affected (9). The same specificity has 
been documented in vivo, where these antibodies inhibit the 
migration of lymphocytes into lymph nodes without altering 
the flow of lymphocytes into Peyer's patches (8, 9). Therefore, 
the selective migration of lymphocytes into various lymphoid 
organs appears to be due, in part,  to specific adhesive mole- 
cules on the surfaces of the lymphocytes and the endothelial 
cells. 
In a  previous report (10), we suggested that an L-fucose/D- 
mannose  specific  lectin  on  the  surface  of rat  lymphocytes 
participates in the attachment to HEV in vitro. This hypoth- 
esis was based on the observation that L-fucose, the structur- 
ally related simple sugar o-mannose (both contain an axial 2- 
OH and an equatorial 4-OH), and the sulfated, L-fucose-rich 
polysaccharide fucoidin inhibit lymphocyte binding.  In con- 
trast, an extensive series of simple sugars and polysaccharides 
fail to inhibit. Finally, Spangrude et al. (l l) recently reported 
that fucoidin blocks the migration oflymphocytes into lymph 
nodes  in  vivo.  This  finding  suggests  that  the  receptor  for 
fucoidin  characterized  in  vitro  participates  in  the  normal 
migration of circulating lymphocytes. 
The present  study  extends  these  initial  findings by  docu- 
menting  the  inhibitory  activity  of  several  phosphorylated 
carbohydrates,  incuding  D-mannose-6-phosphate  (M6P),  D- 
fructose-l-phosphate  (F1P),  and  a  phosphomannosyl-rich, 
core polysaccharide  derived from a  yeast  mannan  (PPME). 
These  data  provide  further  evidence  that  a  carbohydrate- 
binding molecule on the lymphocyte surface may be involved 
in adhesion.  The possible relationship between this receptor 
and previously described phosphomannosyl  receptors  is dis- 
cussed. 
MATERIALS  AND  METHODS 
Chemicals:  Monosaccharides  were obtained from Sigma Chemical Co. 
(St. Louis, MO). Fucoidin (from K & K Labs, Plainview,  NY) and the hydrolysis 
product ofHansenula holstii phosphomannan (PPME; kindly provided by Dr. 
M. E. Slodki, Northern Regional Research Laboratory, Peoria, IL) were used 
without further purification unless indicated. The mannans from the mnnl 
and  mnn2  yeast mutants  were generously provided by  Dr.  C.  E.  Ballou, 
University of California at  Berkeley. Heparin (H3125), chondroitin  sulfate 
(C3254), dextran sulfate (D7515), mannan (M7504), and bovine serum albu- 
min (A4378) were obtained from Sigma Chemical Co. 
Preparation  of Sections:  A nonspecifie antigenic stimulus (0.1-0.2 
ml of a  1:1 emulsion of Freund's complete adjuvant and sheep erythrocytes) 
was administered subcutaneously (to ether-anesthetized, 180 g, female,  Sprague- 
Dawiey rats) in the region of the superficial cervical lymph node chains. This 
procedure increased  both the number and the volume of  lymph nodes recovered 
(compared to untreated animals) without altering the characteristics of the 
adhesive interaction (data not shown). 
5-7 d after the challenge,  animals were killed and the cervical lymph nodes 
were frozen and sectioned as previously  described (10). For some experiments, 
freshly cut frozen sections were air-dried onto slides at room temperature and 
then fixed (0.5-1% freshly  prepared paraformaldehyde in 0.1 M Na-cacodylate 
buffer, pH 7.3, 4°C, 20 min), washed (phosphate-buffered saline, pH 7.4, 40C; 
two dips in three changes of  buffer) and used immediately. The slides  remained 
in  phosphate-buffered saline until  used in the binding assay (<30  min) to 
prevent dehydration. Sections prepared in this manner showed reduced non- 
specific binding (at sites other than the HEV) and enhanced specific binding 
activity (Fig. 1).  Fixation did  not alter the  characteristics of the  adhesive 
interaction since the rank-order-of-potencies  for the mannose phosphates were 
unchanged (Table I). 
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FIGURE  1  Lymphocyte binding to fixed sections.  In  the absence 
of  inhibitors,  lymphocytes  (A)  attach  primarily  to  the  HEV  (the 
perimeter boundaries of which are defined by bars designated with 
B). Lymphocyte binding to non-HEY sites is 50-100-fold lower than 
that to HEV. Bar, 42/~m. x  200. 
TABLE  I 
Unfixed sections  Fixed sections 
Control  I O0 _  I 0  I O0 _+ 13 
Mannose-6-P  7 _  4  23 _  7 
Mannose-1-P  90 _  27  90 +  21 
Inhibitory activity using unfixed and fixed frozen sections. Lymphocytes (2 x 
107 for  unfixed  sections; 1 x  106 for  fixed  sections) were  incubated with 
sugars (4°C; 10 raM; 30 min) then applied to sections (7°C; 80 rpm; 50 rain). 
Sections were then fixed, washed, stained and examined for binding activity 
as described  in  Materials and  Methods.  The  mean :1: the  SEM  for  four 
replicates (unfixed sections) or eight replicates (fixed sections)  are reported. 
Binding Assay:  The procedure, based  on an assay  originally devised 
by Stamper and Woodruff (5), has been described  in detail elsewhere  (10). In 
brief, freshly prepared lymphocyte suspension (from the cervical lymph nodes 
of adult Sprague-Dawley  rats), containing various additives, were layered onto 
either air-dried or fixed, 10/~m sections of peripheral lymph node. After a 15- 
50-min incubation (at 7-10"C with rotary agitation), the cell suspensions were 
decanted and the sections were fixed in glutaraldehyde  (3% for 20 rain at 4"C). 
The sections  were gently washed to remove nouadherent cells and then specific 
binding to the HEV was determined as described in the next section. 
Potential inhibitors (the mono- and polysaccharides) were added to the cell 
suspensions 15-30 rain before the start of the binding assays. The final cell 
concentrations were 1-2 x  107 cells/ml when unfixed sections were used and 
1-5  x  I(P cells/mi when fixed sections were used. Inhibitors were present 
throughout the subsequent binding incubation unless specifically  indicated. 
Ouantitation  of Binding:  Binding  activity was  quantified,  in  a 
single-blind fashion, as described previously (10) by determining the average 
number oflymphocytes bound to the HEV in x 200 microscopic fields (based 
on counts  of multiple fields covering the  entire  section). To facilitate the 
comparison among experiments conducted on different days or using different 
lymph node  sections, the  binding under  each experimental condition was 
expressed relative to the binding of  the control cells as follows:  Binding relative 
to control = (HEV-bound test cells per x 200 microscopic field)/(HEV-bound 
control cells per x 200 microscopic field) ×  100. 
Individual data points represent the mean and standard error of the mean 
(SEM) for measurements on throe to eight separate sections taken from various 
regions  of  the lymph node. When calculated in this fashion, SEMs for individual 
data points ranged from 10 to 20%. 
Alkaline Phosphatase Digestion:  PPME  (400/~/mi) in 10 mM 
Tris-HCI, pH  8.0, was digested with  E.  coil alkaline phosphatase (Sigma 
Chemical Co.) at 320 ~g/ml (4 U/mg) for 24 h at 37"(2 with or without 100 
mM KH2PO4. Na-azide (0.02%) was added to retard bacterial growth during 
the incubation. Samples were dialyzed into MEM+ for testing in the binding 
assay. Phosphate assays (12) were done on samples dialyzed into 10 mM Tris- 
HCI, pH 8.0. Preincubation Experiments:  Assayswerecarriedoutinwhicheither 
the lymphocytes or the HEV sections were preincubated with PPME before the 
quantitation  of binding.  Fixed  lymph node  sections, a  rapid  cell  washing 
procedure, and a  short binding assay (15  min as opposed to 50 rain) were 
employed. For  preincubation of lymphocytes, a  suspension containing  107 
cells/ml was exposed at 4*(2  to PPME (200 ,g/ml), mnn  I mannan (200 #g/ml) 
or medium for 30 rain, washed quickly (three 10-s washes using a Beckman 
Model B microcentrifnge [Beckman Instruments, Inc., Palo Alto, CA]),  and 
tested for binding activity.  The rapid washing procedure resulted in a 900-fold 
dilution of the PPME.  For preincubation of the HEV,  fixed sections were 
pretreated with either PPME (200 #g/ml) or medium at 7"C for 30 rain, washed 
to achieve a 900-fold dilution of the polysaccharide, and assayed for binding 
activity. 
Protein Synthesis:  The rate of protein synthesis in lymphocytes was 
determined by measuring the incorporation of [3H]leucine (ICN Pharmaceuti- 
cals Inc.,  Irvine,  CA; Cat.  No.  20032;  120  Ci/mM) into TCA-precipitable 
counts as previously described (10). 
Surface Charge Determinations:  The  increment  in  negative 
charge density on  the lymphocyte surface, due to  the binding of charged 
carbohydrates, was determined by measuring the electrophoretic mobility of 
cells in the presence of sngars and polysaccharides. The mobilities of individual 
cells per sample were measured in a Zeiss cytopheromeler (Carl Zeiss Co., New 
York, NY) equipped with a rectangular microelectrophoresis  chamber (700 #m 
depth) and a Zn/ZnSO4 electrode assembly. The measurements  were made at 
7.0 +/- 0.1*C in MEM+ containing various phosphorylated sugars or charged 
polysaccharides (pH 7.4).  The ionic strength of the MEM+ with or without 
added polysaccharides was 0.156; the addition of 10 mM D-mannose-l-phos- 
phate (MIP) or M6P increased the ionic strength to 0.176. For each sample 
the cellular electrophoretic mobility was determined from a  series of 40-60 
velocity measurements on individual cells at two stationary levels within the 
microelectrophoresis chamber. All measurements  were made with the polarity 
of the applied electric field (6.0 V/cm) in alternate directions, thereby canceling 
out any effect  of mechanical fluid drift on the net electrophoretic velocity. 
Surface charge density (C/m 2) was calculated from the electrophoretic mobility 
(~m x  s-~/V x cm  -~) using the Gouy-Chapman equation (13). 
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FIGURE 2  Lymphocyte  attachment  in  the  presence  of  various 
monosaccharides  (10 raM). CONT, no-added-sugar control; MAN, 
D-mannose;  M6P, D-mannose-6-phosphate;  MIP, D-mannose-1- 
phosphate; FIP, D-fructose-l-phosphate;  F6P, D-fructose-6-phos- 
phate;  GAL1P, D-galactose-l-phosphate;  GAL6P, D-galactose-6- 
phosphate. Freshly prepared lymphocyte suspensions were prein- 
cubated  with  sugar  (4"C;  15  rain)  and  incubated  over  unfixed, 
frozen sections (7"C; 80 rpm; 50 min). Sections were fixed, washed, 
stained, and examined for binding activity as described previously 
(10).  Each point depicts  the  mean  and  SEM  of  four  replicates. 
Glucose  phosphates  (1  and  6)  showed  no  significant inhibitory 
activity at a concentration of 10 mM (data not shown). 
R  ES U LTS 
Specific, phosphorylated carbohydrates were potent inhibitors 
of the lymphocytes-HEV adhesive interaction in the frozen 
section assay. At l0 raM, the structurally related sugars M6P 
and FIP produced 80-90% inhibition of  binding. In contrast, 
o-mannose- l-phosphate  (MIP),  o-fructose-6-phosphate 
(F6P), the D-galactose phosphates (l and 6) and the D-glucose 
phosphates (l  and 6) had little or no effect (Fig.  2).  M6P 
produced one-half maximal inhibition of binding (I50) at 2- 
3 mM (Fig. 3). Therefore, phosphorylation at the six position 
increased the potency of mannose 25-50-fold 050 =  150 mM 
for o-mannose; see reference 10). 
We reported previously that increasing the ionic strength 
of  the incubation buffer results in a dose-dependent inhibition 
of lymphocyte binding (10).  A  50%  inhibition  of binding 
required a 30% increase in ionic strength. In contrast, M6P 
or FIP inhibit binding by >80%  at concentrations that in- 
crease the ionic strength by only 13%. Furthermore, all the 
sugar phosphates tested increased ionic strength to approxi- 
mately the  same  degree and  yet only M6P  and  F1P  had 
significant inhibitory activity (at 10 mM). Thus a change in 
ionic strength alone cannot account for the inhibitory activity 
of the phosphorylated sugars. 
In light of the M6P effect we tested several yeast mannans 
for inhibitory activity. The mnnl and mnn2 mannans failed 
to inhibit at  1 mg/ml (data not shown). In contrast, PPME, 
derived from the yeast Hansenula holstii, was a potent inhib- 
itor producing one-half maximal inhibition of binding at 10- 
20 #g/ml (~ l0  -s M; Fig. 4). In addition, the inhibitory activity 
of PPME appeared to plateau at concentrations > 100 #g/ml 
(Fig. 4). In several experiments, the PPME-resistant binding 
ranged from 20 to 40% of the control value. 
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FIGURE  3  Dose-re- 
sponse curve for man- 
nose-6-phosphate.  As- 
say  conditions  as  de- 
scribed  in Fig. 2.  Each 
point depicts the mean 
and SEM of four repli- 
cates. 
PPME consists entirely of mannose  and  phosphate  (6:1 
molar ratio). The exposed phosphate residues are estedfied to 
the 6 position of mannose (l 4, 15). These residues are critical 
to the inhibitory activity of PPME, since digestion with alka- 
line  phosphatase  reduced both  its  phosphate  content and 
inhibitory activity (Fig. 5). An excess of free phosphate in the 
digestion mixture prevented the removal of phosphate (via 
product inhibition) and preserved the activity of PPME. 
Preincubation experiments, in  which  a  procedure maxi- 
mized for speed and sensitivity was used, revealed that the 
lymphocyte was the primary target for the action of PPME. 
Preexposure to PPME significantly reduced the attachment 
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FIGURE 4  Dose-response  .~  150 
curve for PPME. Assay con- 
ditions  are  described  in  ¢~ 
Fig. 2.  Each point depicts 
i  the mean and SEM of five  ~  10(] 
replicates.  Similar  results 
were obtained in three in- 
dependent experiments. 
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FIGURE 5  Inhibitory  ac- 
tivity  of  PPME after  re- 
moval  of  exposed  phos- 
phate residues. PPME was 
digested  with E. coil  alka- 
line  phosphatase  (as  de- 
scribed  in  Materials  and 
Methods) with or without 
100 mM  phosphate pres- 
ent.  This  procedure  re- 
sulted  in  a 50% decrease 
+  in  phosphate  content  of 
PPME; 100 mM  phosphate prevented the removal of phosphate 
from PPME. Treated and untreated PPME (200 ,g/ml) were assayed 
for inhibitory activity as described in Fig. 2. Each point depicts the 
mean and SEM of four replicates. 
of lymphocytes relative to both the control and the mnnl- 
mannan-treated cells (Fig.  6).  In contrast, no significant in- 
hibition of  binding was detected when sections were pretreated 
in a similar manner (Fig. 6). Both the preincubations and the 
binding assay were conducted  at temperatures that  inhibit 
endocytosis (4"C and 10*C, respectively). In addition, increas- 
ing the duration of the wash procedure (from 1 to  15 min), 
without  changing  either  the  overall dilution  factor or  the 
duration of the binding assay, significantly reduced the inhi- 
bition by PPME. These data suggest that PPME binds revers- 
ibly to a cell-surface receptor involved in adhesion. 
The activities of the phosphorylated sugars and PPME were 
not due to a generalized toxic effect on the lymphocytes, since 
maximally inhibiting concentrations of these substances nei- 
ther inhibited the rate of protein synthesis (see Materials and 
Methods) nor reduced trypan blue exclusion. Furthermore, 
inhibition cannot be attributed solely to an increase in the 
negative charge on the surface of the lymphocytes. Cellular 
electrophoresis measurements indicated that the charge den- 
sity on the cell surface varied considerably in the presence of 
the various substances tested (Fig. 7). However, there was no 
correlation  between  the  magnitude  of the  negative charge 
density on the lymphocyte surface and the level of binding to 
HEV. For example, dextran sulfate (25 ~g/ml) failed to inhibit 
binding and  yet resulted  in  the greatest increase in  charge 
density. In contrast, M6P (10 mM) was a potent inhibitor but 
produced the smallest increase in charge density. 
DISCUSSION 
In summary, M6P, the structurally related sugar F1P and the 
M6P-rich core phosphomannan PPME are potent inhibitors 
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FIGURE 6  Persistent inhibition of binding after preincubation of 
lymphocytes with PPME. Each point depicts the mean and the SEM 
of five replicates. 
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FIGURE  7  Percent  inhibition of  binding activity  versus  percent 
increase  in  negative  surface  charge  density on the  lymphocyte. 
Clear bars depict binding activity in the presence of carbohydrates; 
solid bars depict charge density on the cell surface. % Inhibition of 
binding =  1 -  (binding in the presence  of sugar)/(binding  in the 
absence  of sugar) x  100. %  Increase surface  charge  density = 
(charge density in presence of sugar)/(charge density in absence of 
sugar)  -  1  x  100. M1P  (mannose-l-phosphate, 10  mM);  M6P 
(mannose-6-phosphate,  10 mM); CHON-S (chondroitin sulfate, 25 
,g/ml); FUC (fucoidin, 10/~g/ml); PPME (core phosphomannan  from 
H.  holstii,  200  ,g/ml);  HEP (heparin,  25  #g/ml);  DEX-S (dextran 
sulfate, 25 t~g/ml). Inhibitory activities pooled from published data 
(Results and ref.  10) in which the SEM ranged from  10 to 20%. 
Surface charge determined by cellular electrophoresis  as described 
in Materials and Methods. Solid bars depict means of measurements 
made on 40-60 individual cells, SEM ranged from 3-4%. Based on 
a Student's t test, the difference in surface charge in the presence 
of M1P and M6P was not statistically  significant.  In contrast,  the 
differences  between the  phosphorylated simple  sugars and  the 
various polysaccharides are significant  (P <  0.01). In addition, the 
differences  between fucoidin  or  PPME on  the  one  hand,  and 
heparin or dextran sulfate on the other, are statistically significant 
(P < 0.01). 
of lymphocyte binding to the HEV of rat peripheral lymph 
nodes in vitro. Inhibitory activity does not result from either 
a generalized metabolic insult to the lymphocyte or a nonspe- 
cific increase  in  the  density  of negative charge at  the  cell 
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sion cannot be ruled out for the high molecular weight poly- 
saccharides (fucoidin and PPME), such a mechanism seems 
unlikely for the monosaccharide inhibitors. These data suggest 
that a phosphomannosyl-binding receptor (lectin-like recep- 
tor) on the lymphocyte surface is involved in the attachment 
oflymphocytes to peripheral node HEV. 
The apparent difference in the maximal inhibitory activities 
of PPME (60% at 200 ~g/ml; see Fig. 4) and M6P (80-90% 
at l0 mM; see Figs. 2 and 3) may reflect the difference in the 
ionic strengths of these solutions. As we reported previously 
(10),  a  13%  increase in ionic strength alone can produce a 
10-30% reduction in the attachment oflymphocytes to HEV 
in vitro. Therefore, the difference in the ionic strengths of the 
disodium M6P and PPME containing solutions, rather than 
an  intrinsic  difference in  the  inhibitory  potencies of these 
compounds, may account for the fact that a  10 mM solution 
of the former (ionic strength of 0.176) inhibits binding to a 
greater extent than a 200 ug/ml solution of the latter (ionic 
strength of 0.156). 
The plateau in PPME-sensitive adhesion suggests that lym- 
phocytes may use more than one adhesive mechanism to bind 
to  the  HEV  of peripheral  lymph  nodes.  The  lymphocyte 
suspensions employed in our studies are heterogeneous; there- 
fore, PPME-sensitive adhesion may be restricted to a specific 
subset  of the  cells  derived  from  peripheral  lymph  nodes. 
Whether this subset conforms to a  functional class (T-cells, 
B-cells, etc.) or includes a mixture of cell types remains to be 
determined.  We are currently investigating this question by 
quantitating the expression of the cell-surface phosphoman- 
nosyl receptor on functional subsets of lymphocytes and by 
comparing the inhibitory activity of PPME in cell suspensions 
enriched for each of these populations. 
The phosphomannosyl specificity of the putative "adhesive 
lectin" on lymphocytes is similar to that described for mem- 
brane receptors implicated in  the  intracellular targeting of 
M6P-containing acid hydrolases to the lysosome. These phos- 
phomannosyl-specific  receptors  are  widely  distributed  in 
mammalian tissues on both the plasma and internal mem- 
branes (l 6-20). This receptor has also been implicated in the 
absorptive pinocytosis of M6P-containing glycoproteins and 
polysaccharides in the human diploid fibroblast (2 l, 22). 
The attachment of lymphocytes to peripheral node HEV 
and the absorptive pinocytosis of MrP-containing acid hydro- 
lases are both inhibited by M6P, F1P, and PPME (Figs. 2 and 
4; and references 17,  23).  M1P,  glucose-6-phosphate, galac- 
tose-6-phosphate,  and  alkaline  phosphatase-treated  PPME 
show relatively little or no activity (Figs.  2 and 5; and refer- 
ences  17,  23).  A  further  parallel  is  that  L-fucose and  D- 
mannose inhibit in both systems (10, 17), although the neutral 
monosaccharides are substantially less active than their phos- 
phorylated counterparts. In contrast to these apparent simi- 
larities  is the  recent  report that  fucoidin,  the  most potent 
inhibitor of lymphocyte-HEV binding thus far identified (10), 
does  not  inhibit  the  attachment  of a  M6P-containing  a- 
mannosidase  (derived  from  the  slime  mold  Dictyostelium 
discoideum) to the surface of intact,  rabbit alveolar macro- 
phages (24).  Additional studies are required to determine the 
structural and functional relationships between the putative 
adhesive lectin on the lymphocyte surface and the phosphom- 
annosyl receptors described above. 
Ligatin is a plasma membrane protein that appears to act 
as a  receptor ("baseplate") for the attachment of peripheral 
glycoproteins in  a  variety  of tissues  (25).  Ligatin  and  its 
associated glycoproteins may play a role in the intercellular 
adhesion of embryonic chick neural retina cells (26).  Ligatin 
has also been shown to bind to phosphorylated monosaccha- 
rides; however, the carbohydrate-binding specificity of ligatin 
varies with the tissue source complicating its comparison with 
the putative adhesive factor on lymphocytes (27). 
The precise contribution  of the phosphomannosyl recep- 
tor-whether  it  is  the  acid  hydrolase  receptor,  a  form  of 
ligatin,  or  some  other  cell  surface  lectin--to  the  adhesive 
interaction between lymphocytes and peripheral lymph node 
HEV remains to be determined.  One possibility is that the 
receptor forms a  direct  bridge  to  the  HEV  by binding  to 
exposed glycocojugates (containing  M6P or structurally re- 
lated  carbohydrates)  on  the  luminal  surface  of the  HEV. 
Alternatively, the phosphomannosyl receptor on the lympho- 
cyte may serve as a baseplate for another adhesive molecule 
with actually forms the bridge to the HEV. A  further possi- 
bility is that the phosphomannosyl receptor is not involved 
directly in attachment, but regulates the activity of  an adhesive 
molecule(s) elsewhere on the cell  surface. Experiments are 
currently underway to determine which model may apply. 
Finally, further study is required to define the relationship 
between  the  phosphosmannosyl  receptor  and  lymphocyte 
membrane antigens implicated as adhesive factors in binding 
to HEV. Chin et al. (8) have described a polyclonal antibody 
that blocks the binding of lymphocytes to HEV of rat periph- 
eral lymph nodes. This antibody recognizes a set of polypep- 
tides on  the  surface of rat lymphocytes. Gallatin  et al.  (9) 
have employed a monoclonal antibody to identify analogous 
molecules on  mouse  lymphocytes. It remains to  be deter- 
mined whether these antigens are phosphomannosyl recep- 
tors,  ligands  for  a  phosphomannosyl  receptor,  or  possibly 
elements of an entirely independent adhesive mechanism. 
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